Monogenic, polygenic, and oligogenic familial hypercholesterolemia

Area of Science:

• Genetics
• Cardiovascular Disease
• Metabolic Disorders

Background:

• Familial hypercholesterolemia (FH) is a common genetic disorder.
• It significantly increases the risk of coronary artery disease.
• Traditionally viewed as monogenic, FH has a more complex genetic basis.

Purpose of the Study:

• To review the current understanding of FH genetics.
• To explore polygenic and oligogenic forms of FH.
• To discuss the implications for diagnosis and management.

Main Methods:

• Review of recent genetic analyses and literature.
• Analysis of allele mutations affecting low-density lipoprotein regulation.
• Synthesis of data on FH subtypes and severity.

Main Results:

• FH can result from mutations in multiple alleles.
• Polygenic and oligogenic FH forms are increasingly recognized.
• Oligogenic FH, involving multiple rare variations, is associated with greater severity.

Conclusions:

• FH encompasses monogenic, oligogenic, and polygenic forms.
• Genetic assessment is crucial for accurate FH diagnosis.
• Risk stratification and cascade screening are vital for affected families.